Clinical Trial Update: A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 dose-selection trial evaluating oral recombinant salmon calcitonin for osteoporosis in healthy postmenopausal women; the study is completed and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Oral recombinant salmon calcitonin (salmon calcitonin (recombinant))

Snippet

Sponsor: Tarsa Therapeutics, Inc. | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2009-09-24